Abstract P183: Human Blood Pressure on Low- or High-sodium Intake is Associated with Divergent Changes of Serum and Urine Metabolites

Xiaoqing Pan,Jonathan Katz,Pengyuan Liu,Kristie Usa,Zhongmin Tian,Mingyu Liang
DOI: https://doi.org/10.1161/hyp.76.suppl_1.p183
IF: 9.8968
2020-01-01
Hypertension
Abstract:Intermediary metabolism, including renal metabolism, is increasingly recognized as an important contributor to the regulation of blood pressure and the development of hypertension, a leading risk factor for disease burden worldwide. Dietary salt intake has significant effects on blood pressure. We test the hypothesis that human blood pressure on low- or high-sodium intake is associated with divergent changes of serum and urinary metabolites. A gas chromatography and mass spectrometry analysis of 192 serum samples from the Dietary Approaches to Stop Hypertension 2 (DASH2 or DASH-Sodium) trial detected 384 metabolites and identified 116. Serum levels of citraconic acid, 1-monostearin and serotonin were associated with systolic or diastolic blood pressure on low- or high-sodium intake after adjustment for covariates (FDR < 0.05). Serum levels of 2-ketoisocaproic acid, glyceric acid, 1-monostearin, ornithine, and β-aminoisobutyric acid were associated with blood pressure differences between low- and high-sodium intakes (FDR < 0.05). An integrated analysis of 33 amino compounds and tricarboxylic acid cycle intermediates indicated that serum and urinary levels were not significantly correlated (FDR < 0.05) for the majority of these metabolites. Blood pressure appeared to be associated with serum, but not urinary, levels of leucine and cystine and urinary, but not serum, levels of β-aminoisobutyric acid. These novel findings support a role for several serum metabolites and renal handling of metabolites in the regulation of human blood pressure on low- or high-sodium intake.
What problem does this paper attempt to address?